Plasmid Derived External Quality Controls for Genetic Testing

  • Tahar van der Straaten
  • Henk-Jan Guchelaar
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1015)

Abstract

Since the human genome has been fully sequenced, and presence of single nucleotide polymorphisms (SNPs) appeared abundant, many studies are associating SNPs with clinical response or even with disease. For some diseases or drug treatments these associations are clear, so that genetic screening for such SNPs or mutations is a standard procedure. For that reason, many different techniques have been developed for fast and easy screening for such specific SNPs/mutations. For reliable screening, the use of controls with known genotypes is indispensable. Plasmids are an ideal tool for making controls which can serve as an inexhaustible source, making new validation superfluous.

In this chapter we describe how plasmid controls can be made using DNA with a heterozygous genotype, and also from DNA of which only one allele is available.

Key words

Genotyping Controls Plasmids Mutagenesis 

References

  1. 1.
    Sanger F, Coulson AR (1975) A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. J Mol Biol 94:441–448PubMedCrossRefGoogle Scholar
  2. 2.
    van der Heiden I, van der Werf M et al (2004) Sequencing: not always the “gold standard”. Clin Chem 50:248–249PubMedCrossRefGoogle Scholar
  3. 3.
    van der Straaten T, Swen J et al (2008) Use of plasmid-derived external quality control samples in pharmacogenetic testing. Pharmacogenomics 9:1261–1266PubMedCrossRefGoogle Scholar
  4. 4.
    van der Straaten T, van Schaik RH (2010) Genetic techniques for pharmacogenetic analyses. Curr Pharm Des 16:231–237PubMedCrossRefGoogle Scholar
  5. 5.
    Ullmann A, Jacob F, Monod J (1967) Characterization by in vitro complementation of a peptide corresponding to an operator-proximal segment of the beta-galactosidase structural gene of Escherichia coli. J Mol Biol 24:339–343PubMedCrossRefGoogle Scholar
  6. 6.
    Yanisch-Perron C, Vieira J, Messing J (1985) Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103–119PubMedCrossRefGoogle Scholar
  7. 7.
    Mezei LM, Storts DR (1994) Purifications of PCR products. In: Griffin HG, Griffin AM (eds) PCR technology: current innovations. CRC, Boca Raton, p 21Google Scholar
  8. 8.
    Robles J, Doers M (1994) pGEM-T Vector Systems troubleshooting guide. Promega Notes 45:19–20Google Scholar
  9. 9.
    Clark JM (1988) Novel non-templated nucleotide addition reactions catalyzed by procaryotic and eucaryotic DNA polymerases. Nucleic Acids Res 16:9677–9686PubMedCrossRefGoogle Scholar
  10. 10.
    Mandel M, Higa A (1970) Calcium-dependent bacteriophage DNA infection. J Mol Biol 53:159–162PubMedCrossRefGoogle Scholar
  11. 11.
    Dagert M, Ehrlich SD (1979) Prolonged incubation in calcium chloride improves the competence of Escherichia coli cells. Gene 6:23–28PubMedCrossRefGoogle Scholar
  12. 12.
    Ausubel FM (1997) Current protocols in molecular biology. Wiley, New YorkGoogle Scholar
  13. 13.
  14. 14.
  15. 15.

Copyright information

© Springer Science+Business Media, LLC 2013

Authors and Affiliations

  • Tahar van der Straaten
    • 1
  • Henk-Jan Guchelaar
    • 1
  1. 1.Department of Clinical Pharmacy and ToxicologyLeiden University Medical CenterLeidenThe Netherlands

Personalised recommendations